Design and synthesis of novel 5-(3,4,5-trimethoxybenzoyl)-4-aminopyrimidine derivatives as potent and selective phosphodiesterase 5 inhibitors: Scaffold hopping using a pseudo-ring by intramolecular hydrogen bond formation

This publication has 16 references indexed in Scilit:

• Exploration of the 5-bromopyrimidin-4(3H)-ones as potent inhibitors of PDE5
  Bioorganic & Medicinal Chemistry Letters, 2013
• Synthesis of quinoline derivatives: Discovery of a potent and selective phosphodiesterase 5 inhibitor for the treatment of Alzheimer's disease
  European Journal of Medicinal Chemistry, 2013
• Discovery of potent, selective, and orally bioavailable PDE5 inhibitor: Methyl-4-(3-chloro-4-methoxybenzylamino)-8-(2-hydroxyethyl)-7-methoxyquinazolin-6-ylmethylcarbamate (CKD 533)
  Bioorganic & Medicinal Chemistry Letters, 2010
• Optimization of the aminopyridopyrazinones class of PDE5 inhibitors: Discovery of 3-[(trans-4-hydroxycyclohexyl)amino]-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido[3,4-b]pyrazin-2(1H)-one
  Bioorganic & Medicinal Chemistry Letters, 2009
• Entry into a new class of protein kinase inhibitors by pseudo ring design
  Bioorganic & Medicinal Chemistry Letters, 2008
• Scaffold hopping
  Drug Discovery Today: Technologies, 2004
• Characteristics of Photoreceptor PDE (PDE6): similarities and differences to PDE5
  International Journal Of Impotence Research, 2004
• Identification of a new chemical class of potent angiogenesis inhibitors based on conformational considerations and database searching
  Bioorganic & Medicinal Chemistry Letters, 2003
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
  Advanced Drug Delivery Reviews, 1997
• Metelation of diazines VIII metalation of 4-chloropyrimidine derivatives new synthesis of trimethoprim
  Tetrahedron Letters, 1993